Skip Ribbon Commands
Skip to main content
SharePoint
 
 
Optimizing choice of treatment for genotype 1 hepatitis C virus using testing for NS5A resistance
A cost-utility analysis for treatment of hepatitis C from the perspective of the Italian National Health Services
 
Pharmerit contributes to ISPOR Task Force report on good practices for mapping
Mapping bridges the gap between available evidence on the effect of a health technology in one metric and the requirement for decision makers to express it in utilities.
 
Pharmerit sponsors NVTAG award at the 2017 Annual NVTAG symposium
Since 2012 Pharmerit has been the proud sponsor of the NVTAG MTA prize
 
Improving economic evaluations of haemophilia to assist treatment choice
Study reviews economic evaluation methods in haemophilia literature and proposes new reporting standards
 
Real-world lurasidone dosing patterns and medication adherence among bipolar patients
This study describes dosing patterns and medication adherence among bipolar disorder patients

 Latest news

2017-02-28
Mapping bridges the gap between available evidence on the effect of a health technology in one metric and the requirement for decision makers to express it in utilities.
2017-02-03
Study reviews economic evaluation methods in haemophilia literature and proposes new reporting standards

 Our people

“It is very satisfying to work at
a place that truly values and
invests in the professional
growth of its staff„
 
“There is a lot of variety in the work
I do at Pharmerit, which challenges
me to develop myself in different
areas of diseases and different
aspects of health economics.„
 
“Working at Pharmerit is generating
the best evidence, taking into
account clients’ needs and best
research practices„
 
“The fun part is working on
a diverse array of projects
and understanding how
different bits fit together to
form a complete picture„
 
 

 Meet us at

Mar
27
2017
Denver, CO (USA)10:00 - 10:00
May
20
2017
Boston, MA (USA)12:00 - 12:00
Jun
17
2017
Rome, Italy11:00 - 11:00
Retrieving Data